2025 Is Shaping Up To Be A Big Year For This Drug Maker Working To Cure Dementia

Lisa Ricciardi, President and CEO of Cognition Therapeutics CGTX, was recently a guest on Benzinga's All-Access.

Cognition Therapeutics is a neuroscience company that is developing oral medications to treat neurodegenerative disorders, with recent breakthroughs in the treatment of dementia with Lewy bodies (DLB) and Alzheimer's disease.

Ms. Ricciardi was on the program to discuss exciting developments coming in 2025.

Watch the full interview here:

Featured photo by Milad Fakurian on Unsplash.

This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.